Entertainment Desk:
In just two years, Rashmika Mandanna has established herself as a dominant force in Indian cinema, outperforming Bollywood’s top actresses at the box office.
With three back-to-back blockbusters—Animal, Pushpa 2: The Rule, and Chhaava—the 28-year-old star has amassed a staggering ₹3300 crore worldwide. Her remarkable success in the Hindi market, contributing ₹1850 crore in net collections, has set a new benchmark in the industry.
Over the past 16 months, Rashmika’s three theatrical releases have shattered records. Pushpa 2: The Rule became a pan-India sensation, collecting ₹812 crore in the Hindi market alone.
Animal, a high-octane action thriller, garnered ₹503 crore, while the historical drama Chhaava has already surpassed ₹532 crore, with numbers still climbing. This extraordinary streak positions her as Bollywood’s most bankable actress in recent times.
BEATING BOLLYWOOD VETERANS
For years, Deepika Padukone dominated the box office, particularly after Priyanka Chopra moved to Hollywood. Alia Bhatt, too, had been leading the new generation of actresses.
However, Rashmika’s phenomenal rise has overshadowed them both. Since 2023, Deepika’s five major releases have amassed over ₹1800 crore in Hindi, while Alia’s films have grossed a mere ₹300 crore. This stark contrast highlights Rashmika’s unprecedented dominance.
A STAR BEYOND THE MALE LEADS
Critics may argue that Rashmika’s success is largely due to her co-stars, but the same can be said for Deepika, Kareena Kapoor, and other leading actresses.
Her consistent presence in high-grossing films suggests she has become the preferred choice for mass entertainers alongside superstars. Her versatility across different genres has further solidified her reputation.
WHAT’S NEXT?
The actress shows no signs of slowing down. She will next be seen in Salman Khan’s Sikandar, which is expected to be another major box office hit.
Additionally, she has signed on for Maddock’s horror-comedy Thama and the pan-India action film Kubera, ensuring her dominance continues well into 2025 and beyond.